PAYX vs STRO · P/E 22, rev $5.57B vs rev $62.0M
Paychex Inc (PAYX) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
Paychex Inc (PAYX) is a software - application company listed on NASDAQ.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported PAYX revenue for 2025-05-31 was $5.57B. Net income was $1.66B. Revenue was up 5.6% from 2024-05-31 to 2025-05-31. PAYX currently screens at market cap $34.96B and trailing P/E 21.5.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
PAYX currently screens at market cap $34.96B and trailing P/E 21.5. STRO currently screens at market cap $470.8M.
Not investment advice. Open the PAYX and STRO stock pages for the full models.
Not investment advice.